Sarah Cavanaugh serves as Executive at Celldex Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sarah Cavanaugh has executed 16 insider transactions totaling $2.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 30, 2024 involved exercising options for 10,750 shares valued at $29.9K.
Sarah Cavanaugh currently holds 12,610 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Cavanaugh has been a net seller of CLDX stock. They have purchased $5.1K and sold $2.5M worth of shares.
Sarah Cavanaugh's most recent insider trade was on May 30, 2024, when they sold 10,750 shares at $2.78 per share.
Get notified when new Form 4 filings are submitted
| 10,103 |
| $9.02 |
| Discretionary |
| May 30, 2024 | CLDX | $703.4K | Sale | 20,853 | $33.73 | Discretionary |
| Aug 18, 2022 | CLDX | $49.3K | Sale | 1,355 | $36.38 | Discretionary |
| Aug 18, 2022 | CLDX | $12.2K | Option Exercise | 1,355 | $9.02 | Discretionary |
| Aug 17, 2022 | CLDX | $87.0K | Option Exercise | 31,312 | $2.78 | Discretionary |
| Aug 17, 2022 | CLDX | $1.2M | Sale | 31,312 | $36.73 | Discretionary |
| Dec 8, 2021 | CLDX | $56.7K | Option Exercise | 5,466 | $10.38 | Discretionary |
| Dec 8, 2021 | CLDX | $292.9K | Sale | 7,323 | $40.00 | Discretionary |
| Dec 8, 2021 | CLDX | $16.8K | Option Exercise | 1,857 | $9.02 | Discretionary |
| Nov 1, 2021 | CLDX | $2.6K | Option Exercise | 938 | $2.78 | Discretionary |
| Nov 1, 2021 | CLDX | $189.8K | Sale | 4,302 | $44.11 | Discretionary |
| Nov 1, 2021 | CLDX | $88.2K | Sale | 2,120 | $41.62 | Discretionary |
| Nov 1, 2021 | CLDX | $38.8K | Sale | 901 | $43.06 | Discretionary |
| Nov 1, 2021 | CLDX | $45.3K | Option Exercise | 5,018 | $9.02 | Discretionary |
| Jun 10, 2020 | CLDX | $5.1K | Purchase | 1,050 | $4.83 | Discretionary |